Dashboard
Manage Tickers

TELATELA Bio, Inc.


$ 2.69 $ 0.13 (5.08 %)    

Wednesday, 18-Sep-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ na
$ 2.58
$ 2.69 x 291
$ 2.71 x 300
$ 2.57 - $ 2.76
$ 2.40 - $ 8.73
37,817
na
66.48M
$ 1.08
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

crude-oil-down-2-paysafe-shares-surge-after-q2-results
Crude Oil Down 2%; Paysafe Shares Surge Af...
08/13/2024 18:30:30

sp-500-gains-1-home-depot-earnings-top-views
S&P 500 Gains 1%; Home Depot Earnings Top ...
08/13/2024 16:15:58

lake-street-maintains-buy-on-tela-bio-lowers-price-target-to-8
Lake Street Maintains Buy on TELA Bio, Low...
08/13/2024 16:09:57

Lake Street analyst Frank Takkinen maintains TELA Bio (NASDAQ:TELA) with a Buy and lowers the price target from $14 to $8.

nasdaq-surges-200-points-us-producer-prices-increase-01-in-july
Nasdaq Surges 200 Points; US Producer Pric...
08/13/2024 13:54:30

canaccord-genuity-maintains-buy-on-tela-bio-lowers-price-target-to-12
Canaccord Genuity Maintains Buy on TELA Bi...
08/13/2024 12:11:21

Canaccord Genuity analyst Caitlin Cronin maintains TELA Bio (NASDAQ:TELA) with a Buy and lowers the price target from $14 to...

jmp-securities-maintains-market-outperform-on-tela-bio-lowers-price-target-to-12
JMP Securities Maintains Market Outperform...
08/13/2024 11:58:45

JMP Securities analyst David Turkaly maintains TELA Bio (NASDAQ:TELA) with a Market Outperform and lowers the price target f...

piper-sandler-maintains-overweight-on-tela-bio-lowers-price-target-to-8
Piper Sandler Maintains Overweight on TELA...
08/13/2024 11:23:43

Piper Sandler analyst Matt O'Brien maintains TELA Bio (NASDAQ:TELA) with a Overweight and lowers the price target from $...

tela-bio-sees-fy24-revenue-745m-766m-vs-75405m-est
TELA Bio Sees FY24 Revenue $74.5M-$76.6M V...
08/12/2024 20:32:37

tela-bio-q2-2024-gaap-eps-051-misses-044-estimate-sales-16091m-miss-18460m-estimate
TELA Bio Q2 2024 GAAP EPS $(0.51) Misses $...
08/12/2024 20:19:09

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.44) by...

canaccord-genuity-maintains-buy-on-tela-bio-maintains-14-price-target
Canaccord Genuity Maintains Buy on TELA Bi...
07/25/2024 13:16:41

Canaccord Genuity analyst Caitlin Cronin maintains TELA Bio (NASDAQ:TELA) with a Buy and maintains $14 price target.

piper-sandler-reiterates-overweight-on-tela-bio-lowers-price-target-to-10
Piper Sandler Reiterates Overweight on TEL...
05/10/2024 13:26:20

Piper Sandler analyst Matt O'Brien reiterates TELA Bio (NASDAQ:TELA) with a Overweight and lowers the price target from ...

tela-bio-increases-fy24-revenue-guidance-from-74m-76m-to-745m-765m-est-7494m
TELA Bio Increases FY24 Revenue Guidance F...
05/09/2024 21:33:44

tela-bio-q1-2024-adj-eps-054-misses-050-estimate-sales-16603m-beat-16319m-estimate
TELA Bio Q1 2024 Adj EPS $(0.54) Misses $(...
05/09/2024 21:15:13

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.50) by...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
05/09/2024 20:31:07

tela-bio-announces-us-commercial-launch-of-robotic-compatible-ovitex-ihr-designed-for-use-in-laparoscopic-and-robotic-assisted-inguinal-hernia-repair
TELA Bio Announces U.S. Commercial Launch ...
04/15/2024 11:28:42

jmp-securities-reiterates-market-outperform-on-tela-bio-maintains-15-price-target
JMP Securities Reiterates Market Outperfor...
03/22/2024 17:12:06

JMP Securities analyst David Turkaly reiterates TELA Bio (NASDAQ:TELA) with a Market Outperform and maintains $15 price target.

piper-sandler-maintains-overweight-on-tela-bio-lowers-price-target-to-12
Piper Sandler Maintains Overweight on TELA...
03/22/2024 14:15:18

Piper Sandler analyst Matt O'Brien maintains TELA Bio (NASDAQ:TELA) with a Overweight and lowers the price target from $...

tela-bio-expects-full-year-2024-revenue-of-74m-76m-representing-27-30-yy-growth-est-75196m
TELA Bio Expects Full Year 2024 Revenue Of...
03/21/2024 21:00:29

recap-tela-bio-q4-earnings
Recap: TELA Bio Q4 Earnings
03/21/2024 20:20:12

tela-bio-q4-2023-gaap-eps-053-misses-044-estimate-sales-16998m-beat-16392m-estimate
TELA Bio Q4 2023 GAAP EPS $(0.53) Misses $...
03/21/2024 20:16:52

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.44) by...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION